Lindsey Rolfe

CIK: 0001650504

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CERO

CERO THERAPEUTICS HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CERO
CERO THERAPEUTICS HOLDINGS, INC.
Jan 7, 2026
Award(A)
Stock Option (Right to Buy)
Direct
690.9K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
9.3K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Mar 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
17.9K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Feb 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
127.5K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Dec 2, 2024
Award(A)
Stock Option (Right to Buy)
Direct
127.5K shares-

		Type	Shares	Price		Ownership
Jan 7, 2026	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	690,900	-	-	Direct
May 30, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	9,326	-	-	Direct
Mar 4, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	17,923	-	-	Direct
Feb 24, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	127,500	-	-	Direct
Dec 2, 2024	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	127,500	-	-	Direct

1-5 of 5 transactions

About Rolfe Lindsey

Rolfe Lindsey (SEC CIK 0001650504) files insider reports with the SEC as Director of CERO THERAPEUTICS HOLDINGS, INC. (CERO).

Signal8 holds 5 ownership filings by Rolfe Lindsey, all Form 4s, filed between Dec 4, 2024 and Jan 9, 2026. Those filings report 5 transactions, from Dec 2, 2024 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rolfe Lindsey's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Rolfe Lindsey

Jan 7, 2026: Grant or award of CERO derivative securities (Form 4, code A).
May 30, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Mar 4, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Feb 24, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Dec 2, 2024: Grant or award of CERO derivative securities (Form 4, code A).

Other insiders filing for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Francois Eric, Director
LAPORTE KATHLEEN, Director
Pierce Kristen, Chief Development Officer
Patel Shami, Director
ATWOOD BRIAN G, Director
Ehrlich Christopher B, Chairman and CEO

How to read Form 4 transaction codes